Private Equity

Andreas Szakacs Productions unveils "Shadow Fist," an MMA drama built on a new financial model that could change how independent films get made.

An Australian firm's new modular smelter aims to unlock stranded iron ore value, promising lower-cost, clean steel and a manufacturing revival.

Laird Superfood acquires Navitas for $38.5M, fueled by a $50M Nexus Capital investment, creating a new powerhouse in the functional nutrition market.

After a strategic pivot and R&D setbacks, Korro Bio secures an $85M lifeline to advance its novel RNA-editing drug for rare metabolic diseases.

Data shows Beren Therapeutics' drug slows progression and boosts survival for infantile-onset NPC, a rare disorder with no approved US treatments.

PitchBook integrates its private market data into Perplexity's AI, promising a new era of fast, verifiable, and conversational financial intelligence.

Amid a complex healthcare market, The Ensign Group will outline its aggressive growth and operational playbook for investors at the upcoming Oppenheimer conference.

BRC Group Holdings announced a major debt reduction, but a history of late filings, shareholder dilution, and high-risk bets cast a shadow on its recovery.

A landmark housing bill meant to ease affordability faces fierce opposition for a new rule that could stifle rental construction and drive up costs.

Women will soon control over 40% of global wealth, yet many feel unprepared. A new HSBC study reveals why financial 'fluency' is the missing link.

Kendra Dinkins makes history as ECA Chicago's first Black female president, vowing to champion diversity and empower a new generation of contractors.

A new report reveals a massive care gap for 76 million US cats, offering a $34 billion roadmap for vets to boost revenue and improve feline health.

A global campaign is rebranding the canned sardine as a weapon against metabolic disease. We investigate the science, the strategy, and a $12 wellness plan.

A 47% surge in natural gas reserves, unlocked by advanced tech in Italy's Po Valley, positions AleAnna to ease import reliance while pursuing a green push.

As Argan prepares its Q4 results, investors are watching if its record backlog and dual energy strategy can sustain its powerful year-end performance.

Third Avenue Real Estate Value Fund's distinct, value-driven strategy has once again been recognized for its superior long-term, risk-adjusted performance.

Guardian Recovery elevates marketing veteran DJ Prince to Chief Strategy Officer, signaling a new era of strategic growth and operational efficiency.

New research shows a telehealth model boosting GLP-1 results to over 26% weight loss, but its reliance on unapproved compounded drugs raises safety flags.

After a massive stock drop, ODDITY Tech signals confidence with an expanded $200M share buyback. Is it a sign of value or a maturing growth story?

Veteran executive search leader Adam Evans joins The Elliot Group as EVP, signaling a strategic push into the high-growth health, auto, and pet sectors.